Tobira Therapeutics (TBRA) Misses Q1 EPS by 12c

Tobira Therapeutics (NASDAQ: TBRA) reported Q1 EPS of ($0.65), $0.12 worse than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Tobira Therapeutics (TBRA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c